GD 48
Alternative Names: GD-48Latest Information Update: 28 Aug 2020
Price :
$50 *
At a glance
- Originator Griffin Discoveries
- Class
- Mechanism of Action Histamine H4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Rheumatoid arthritis
Highest Development Phases
- No development reported Rheumatoid arthritis
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Rheumatoid-arthritis in Netherlands
- 19 Jul 2016 GD 48 is available for licensing as of 19 Jul 2016. http://www.griffindiscoveries.com/
- 19 Jul 2016 Early research in Rheumatoid arthritis in Netherlands (unspecified route)